Consolidated Statements of Cash Flows - USD ($) $ in Millions		12 Months Ended
		Dec. 31, 2019		Dec. 31, 2018	Dec. 31, 2017
CASH PROVIDED BY (USED IN) OPERATING ACTIVITIES
Net earnings		$ 7,728		$ 8,286	$ 6,341
Adjustments to reconcile net earnings to operating cash flows:
Depreciation and amortization		964		989	875
Deferred income tax (benefit) provision		(141)		(100)	(501)
Asset impairment and exit costs, net of cash paid (Note 21)		371		(3)	(10)
Cash effects of changes in:
Receivables, net		(331)		53	(92)
Inventories		(548)		(613)	730
Accounts payable		451		(51)	425
Accrued liabilities and other current assets		1,108		910	(554)
Income taxes		75		(135)	1,370
Pension plan contributions		(200)		(110)	(66)
Other		613	[1]	252	394
Net cash provided by operating activities		10,090		9,478	8,912
CASH PROVIDED BY (USED IN) INVESTING ACTIVITIES
Capital expenditures		(852)		(1,436)	(1,548)
Investments in unconsolidated subsidiaries and equity securities		(31)		(63)	(111)
Deconsolidation of RBH (Note 22)		(1,346)	[2]	0	0
Net investment hedges		386		416
Net investment hedges					(1,527)
Other		32		85	103
Net cash used in investing activities		(1,811)		(998)	(3,083)
Short-term borrowing activity by original maturity:
Net issuances (repayments) - maturities of 90 days or less		(364)		255	(127)
Issuances - maturities longer than 90 days		989		0	1,634
Repayments - maturities longer than 90 days		(989)		0	(1,634)
Long-term debt proceeds		3,819		0	6,850
Long-term debt repaid		(3,998)		(2,484)	(2,551)
Dividends paid		(7,161)		(6,885)	(6,520)
Sale (purchase) of subsidiary shares to/(from) noncontrolling interests (Note 6)		51			5
Sale (purchase) of subsidiary shares to/(from) noncontrolling interests (Note 6)				(81)
Other		(408)		(456)	(426)
Net cash used in financing activities		(8,061)		(9,651)	(2,769)
Effect of exchange rate changes on cash, cash equivalents and restricted cash		27		(685)	1,085
Cash, cash equivalents and restricted cash:
Increase (Decrease)	[3]	245		(1,856)	4,145
Balance at beginning of year	[3]	6,620		8,476	4,331
Balance at end of year	[3]	6,865		6,620	8,476
Cash Paid:
Interest		800		882	1,050
Income taxes		$ 2,430		$ 2,749	$ 3,403

[1] Includes the Loss on Deconsolidation of RBH ($239 million) and the Canadian tobacco litigation-related charge ($194 million) that were included in marketing, administration and research costs in the consolidated statements of earnings for the year ended December 31, 2019. For further details on these charges, see Note 22. Deconsolidation of RBH.

[2] Includes deconsolidation of RBH cash and cash equivalents of $1,323 million and restricted cash of $23 million.

[3] The amounts for cash and cash equivalents shown above include restricted cash of $4 million, $27 million and $29 million as of December 31, 2019, 2018 and 2017, respectively, which were included in other current assets in the consolidated balance sheets.